Guangzhou Boyuan Outdoor Products Co., Ltd. (hereinafter referred to as "Boyuan") is a specialized biotechnology and chemical trading enterprise based in Guangzhou, China, dedicated to the research, development, sourcing, and global distribution of high-purity peptide products and related biochemical reagents. Originally established with a focus on outdoor equipment and accessories, the company has strategically pivoted and expanded its core business to become a recognized supplier in the competitive peptide market, leveraging Guangzhou's robust logistics infrastructure and its proximity to major chemical and pharmaceutical manufacturing hubs in the Pearl River Delta. Boyuan's peptide product portfolio encompasses a wide array of bioactive peptides, including but not limited to research-grade SM, TR, RT, Selank, Semax, various GHRPs (Growth Hormone-Releasing Peptides) such as GHRP-2, GHRP-6, Ipamorelin, as well as NAD⁺ (Nicotinamide Adenine Dinucleotide), MGF (Mechano Growth Factor), and many other custom peptide sequences. Each product is meticulously manufactured in state-of-the-art, GMP-compliant facilities, and undergoes stringent quality control processes, including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis, to ensure purity levels typically exceeding 98% or even 99%, with detailed Certificates of Analysis (CoA) readily available for customer verification. Boyuan offers peptides in various forms to meet diverse application needs, primarily as sterile lyophilized white powders or loose blocks, supplied in standard glass vials with precise dosages ranging from 1mg, 2mg, 5mg, 10mg to custom bulk quantities, all clearly labeled with product name, purity, net content, batch number, storage conditions (typically requiring -20°C or -80°C for long-term preservation), and the corresponding CAS numbers such as 53-84-9 for NAD⁺, 77591-33-4 for TB-500 (if applicable), or sample codes for SM, TR, RT. The company assigns unique model numbers to each specification — for instance, BY-SM-5MG for SM 5mg, BY-TR-10MG for TR 10mg, BY-RT-2MG for RT 2mg, BY-NAD-100MG for NAD⁺ 100mg — ensuring clear traceability and streamlined ordering for research institutions, pharmaceutical companies, and laboratory customers worldwide. Recognizing that peptides are typically intended for in vitro laboratory research, scientific studies, and preclinical development rather than human or veterinary use (unless explicitly authorized), Boyuan strictly adheres to international trade regulations and ethical sourcing guidelines. The company provides professional technical support, stable cold-chain logistics (including freeze packs and vacuum-insulated shipping containers) to maintain product integrity during transit, and responsive after-sales service. With a dedicated quality assurance team, Boyuan can also offer custom synthesis services for rare or modified peptide sequences, providing clients with tailored solutions and flexible lead times. The company's commitment to transparency is reflected in its practice of furnishing complete documentation, including MSDS (Material Safety Data Sheets), COA, HPLC chromatograms, and stability study reports upon request. Over the years, Boyuan has cultivated a reliable distribution network covering North America, Europe, Southeast Asia, and Australia, building long-term partnerships based on consistent product quality, competitive pricing, and professional communication. Despite its origins in outdoor products, Boyuan's successful transformation into a peptide supply specialist demonstrates its agility, technical competence, and customer-centric philosophy. The company continues to invest in refining its quality management systems, expanding its peptide library, and exploring new bioactive molecules to support cutting-edge scientific discovery. For any inquiries regarding pricing, bulk orders, custom synthesis, or technical specifications, Guangzhou Boyuan Outdoor Products Co., Ltd. welcomes clients to initiate direct correspondence through its official sales channels, where a knowledgeable representative will respond with detailed product information, current stock availability, and shipment quotations tailored to specific research requirements. Through unwavering dedication to excellence, Boyuan strives to be a trusted partner in the global peptide supply chain, empowering researchers and developers with premium biochemical tools for tomorrow's breakthroughs.
BBG70 represents a sophisticated, research‑grade peptide formulation specifically engineered for advanced laboratory investigations into tissue support, extracellular matrix organization, and cellular regeneration mechanisms. This tri‑peptide synergy system combines three well‑documented bioactive peptides—Peptide A, GHK‑Cu, and Peptide B—in precisely measured quantities to facilitate controlled in vitro and ex vivo studies. Each component has been selected based on its distinct molecular profile and mechanism of action, allowing researchers to investigate potential additive or synergistic effects under standardized experimental conditions. The lyophilized powder format ensures exceptional stability during storage and transport, with each vial containing the exact specified peptide content verified through high‑performance liquid chromatography (HPLC) analysis. The white, amorphous powder exhibits excellent solubility in sterile water, phosphate‑buffered saline (PBS), and other standard laboratory buffers, facilitating seamless reconstitution for experimental protocols. BBG70 is manufactured under stringent quality control standards, with each batch accompanied by a Certificate of Analysis (COA) detailing purity levels, mass spectrometry verification, and endotoxin testing results.
From a research perspective, this tri‑peptide combination offers investigators a multi‑modal approach to studying fundamental biological processes. GHK‑Cu (copper tripeptide) serves as a naturally occurring plasma peptide with high copper affinity, demonstrating measurable effects on collagen synthesis pathways, fibroblast activity, and inflammatory cytokine modulation in cell culture systems. The second peptide component (designated Peptide A in this formulation) has been characterized in preclinical literature for its influence on angiogenesis, cell migration, and tissue integrity parameters in various experimental models. The third component (Peptide B) has been described for its role in actin regulation, cell differentiation, and extracellular matrix remodeling. When combined in the BBG70 formulation, these peptides allow researchers to investigate potential complementary mechanisms across multiple biological cascades simultaneously. The GHK‑Cu component provides a foundation for studying copper‑dependent enzymatic processes and matrix metalloproteinase regulation, while Peptide A offers a platform for examining growth factor signaling and vascular support pathways. Peptide B contributes to cytoskeletal dynamics and cell motility studies, creating a comprehensive research tool for investigators exploring tissue‑level responses.
BBG70 is supplied as a sterile, lyophilized preparation requiring appropriate laboratory handling procedures. The product is intended exclusively for research purposes and is not approved for human or veterinary use under any jurisdiction. Recommended storage conditions include maintaining the product at −20°C in an airtight, desiccated environment protected from light exposure. Once reconstituted with an appropriate sterile buffer, aliquots should be stored at −80°C for long‑term preservation or at 2–8°C for short‑term experimental use, with careful attention to avoiding repeated freeze‑thaw cycles which may compromise peptide integrity. Each BBG70 unit contains three separate vials—one vial of Peptide A (10 mg), one vial of GHK‑Cu (50 mg), and one vial of Peptide B (10 mg)—allowing researchers the flexibility to reconstitute components individually or combine them according to specific experimental designs. This modular configuration supports dose‑response studies, comparative analyses, and sequential application protocols without requiring multiple product purchases.
BBG70 is manufactured and distributed in strict compliance with research‑use‑only (RUO) regulations. The product has not been evaluated by the FDA, EMA, or any other regulatory agency for diagnostic, therapeutic, or prophylactic applications. Sales are restricted to qualified research institutions, laboratories, and investigators with established research protocols. Documentation regarding raw material sourcing, synthesis pathways, purification methods, and analytical testing is available upon request for institutional review board (IRB) or animal care and use committee (ACUC) submissions. All production processes follow Good Manufacturing Practice (GMP) guidelines for research‑grade biochemicals, with third‑party analytical verification ensuring batch‑to‑batch consistency. Endotoxin levels are maintained below 1.0 EU/μg, and sterility testing confirms the absence of bacterial or fungal contamination. These quality benchmarks align with standard requirements for cell culture applications and small animal model studies commonly conducted in academic and pharmaceutical research settings.
BBG70 is specifically designed for researchers investigating cellular regeneration mechanisms, extracellular matrix biology, wound healing models, connective tissue studies, and dermatological research applications. The tri‑peptide composition provides a versatile tool for both fundamental mechanistic studies and translational research pipelines. Its utility spans multiple experimental platforms, including in vitro cell culture systems, ex vivo tissue preparations, and in vivo animal model investigations under approved institutional protocols. For researchers requiring customized ratios or additional peptide components, the manufacturer offers technical consultation and custom synthesis services. Bulk quantities and alternative vial configurations may be available for large‑scale or longitudinal studies. BBG70 represents a state‑of‑the‑art research tool for the scientific community investigating peptide‑mediated biological processes at the molecular level.
Brazil
United States
Canada
France
Netherlands
Portugal
Pls input...